They further suggest that bromodomain-containing protein 4 (BRD4) enhances this process, as inhibiting BRD4 reduces the activity of MMP-2 and MMP-9, thereby suppressing the progression and invasiveness of HCC cells [50]. The gene discussed is MMP2; the disease is hepatocellular carcinoma.